Richardson, KathrynFox, ChrisMaidment, IanSteel, NicholasLoke, Yoon K.Arthur, AntonyMyint, Phyo KGrossi, Carlota M.Mattishent, KatharinaBennett, KathleenCampbell, Noll L.Boustani, MalazRobinson, LouiseBrayne, CarolMatthews, Fiona E.Savva, George M.2018-04-302018-04-302018-04-25Richardson, K, Fox, C, Maidment, I, Steel, N, Loke, Y K, Arthur, A, Myint, P K, Grossi, C M, Mattishent, K, Bennett, K, Campbell, N L, Boustani, M, Robinson, L, Brayne, C, Matthews, F E & Savva, G M 2018, 'Anticholinergic drugs and risk of dementia : case-control study', BMJ, vol. 361, k1315. https://doi.org/10.1136/bmj.k13150959-8146PubMedCentral: PMC5915701ORCID: /0000-0003-3852-6158/work/163199059http://hdl.handle.net/2164/10384We thank Ms Tarita Murray-Thomas (Medicines and Healthcare products Regulatory Agency) for extracting the CPRD data, Mr Keshav Bajaj (Aston University) for assisting with drugs coding, and Prof Ryan Carnahan for providing the Anticholinergic Drug Scale (ADS). We thank Mr Barry Plumpton, Mrs Ann McLauchlan, Mrs Barbara di Vita, and Mrs Gloria Swan for their assistance and oversight as Alzheimer’s Society Research Network Volunteers. Funding: This research was supported by the Alzheimer’s Society (AS-PG-2013-017). The funders had no role is the design of the study or the interpretation of the findings.12300619engR Medicine (General)Supplementary DataR1Journal article10.1136/bmj.k1315361